Differentiation and breast cancer

Medicina

Volumn 57, Issue SUPPL. 2, 1997, Pages 81-91

  Russo, Jose ^a   Russo, Irma H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Cellular differentiation

Indexed keywords

GROWTH PROMOTOR;

ANIMAL; ARTICLE; BREAST; BREAST TUMOR; CELL DIFFERENTIATION; CELL TRANSFORMATION; CYTOLOGY; DISEASE MODEL; DISEASE PREDISPOSITION; EPITHELIUM CELL; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; PARITY; PATHOLOGY; PHYSIOLOGY; PREGNANCY; RAT; RISK FACTOR;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; FEMALE; GROWTH SUBSTANCES; HUMANS; PARITY; PREGNANCY; RATS; RISK FACTORS;

EID: 0031317750     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Russo J, Russo IH. Development of the human mammary gland. In: Neville MC, Daniel CW (eds): The Mammary Gland Development, Regulation, and Function. New YorK: Plenum 1987, 67-93.
2. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect, 1996; 104: 938-67.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, CA-Cancer J Clin 1996; 65: 5-27.
4. MacMahon B, Cole P, Liu M, Lowe CR, Mirra AP, Ravinihar B, et al. Age at first birth and breast cancer risk. Bull WHO 1970; 34: 209-21.
5. McGregor DH, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I, Beebe GW. Breast Cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950-1989. J Natl Cancer Inst 1977; 59: 799-811.
6. De Waard F, Trichopoulos D. A unifying concept of the etiology of breast cancer, Int J Cancer 1988; 41: 666-9.
7. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 1993; 259: 633-8.
8. Boring CC, Squires TS, Tang T. Cancer Statistics CA-Cancer J Clin 1993; 43: 72-6.
9. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: The nurses health study. Am J Epidemiol 1994; 129: 819-35.
10. Russo J, Russo IH. Biological and molecular bases of mammary carcinogenesis. Lab Invest 1987; 57: 112-37.
11. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990; 62: 1-32.
12. Russo J, Mills MJ, Moussalli MJ, Russo IH. Influence of breast development and growth properties in vitro. In Vitro Cell Develop Biol 1989; 25: 643-9.
13. Russo J, Reina D, Frederick J, Russo IH. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 1988; 48: 2837-57.
14. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992; 23: 211-8.
15. Russo J, Romero AL, Russo IH. Architectural pattern of the normal and cancerous breast under the influence of parity. J Cancer Epidemiol Biomarkers & Prevention. 1994; 3: 219-24.
16. South SA, Yankov VI, Evans WS. Normal reproductive neuro-endocrinology in the female. Endocrine Metab Clin NA 1993; 22: 1-22.
17. Marshall JC, Griffin ML. The role of changing pulse frequency in the regulation of ovulation. Hum Reprod 1993; (suppl 2): 57-68, 1993.
18. Carr BR. Disorders of the ovary and female reproductive tract. In Wilson, J. D. and Foster, D W. (eds.) Williams Textbook of Endocrinology, Philadelphia: WB Saunders Co 1992; 733-57.
19. Espey LL, Ben Halim IA. Characteristics and control of the normal menstrual cycle. Obstet Gynecol Clin NA 1990; 17: 275-8.
20. MacLeod RM. Regulation of prolactin secretion. In Martini, L. and Ganong, W.F. (eds.) Frontiers in neuroendocrinology. New York: Raven Press 1976; 164-94.
21. Roseff SJ, Bangah ML, Kettel LM, et al: Dynamic changes in circulating inhibin levels during the lutealfollicular transition of the human menstrual cycle. J Clin Endocrinol Metab 1989; 69: 1033-8.
22. Dye RB, Rabinovici J, Jaffe RB. Inhibin and activin in reproductive biology. Obstet Gynecol Surv 1992; 47: 173-6.
23. Russo IH, Russo J. In Teicher BA (ed.) Chorionic gonadotropin: A tumonstatic and preventive agent in breast cancer. Drug Resistance in Oncology, New York, Basel, Hong Kong: Marcel Dekker, Inc 1993; 537-60.
24. Russo IH, Russo J. Role of hCG and inhibin in breast cancer. Int J Oncol 1994; 4: 297-306.
25. Nisula BC, Taliadouros GS, Carayon P. In: Segal, S.J. (ed.). Chorionic Gonadotropin, Primary and secondary biologic activities intrinsic to the human chorionic gonadotropin molecule. New York: Plenum Press, 1980; 17-35.
26. Russo J, Calaf G, Russo IH. A critical approach to the malignant transformation of human breast epithelial cells. CRC Critical Rev Oncogen 1993; 4: 403-17.
27. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol, Biomarkers & Prevention 1994; 3: 353-64.
28. Russo J, Russo IH. Hormonally induced differentiation: A novel apprach to breast cancer prevention. J Cell Biochem 1995; 22: 58-64.
29. Russo J, Russo IH. Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine-Related Cancer 1997; 4: 1-15.
30. Kumar V, Stack GS, Berry M, Jin JR, Chambon P. Functional domains of the human estrogen receptor. Cell 1987; 51: 941-51.
31. King RJB. Effects of steroid hormones and related compounds on gene transcription. Clin Endocrinol 1992; 36: 1-14.
32. Soto AM, Sonnenschein C. Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev 1987; 48: 52-8.
33. Huseby RA, Maloney TM, McGrath CM. Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vitro. Cancer Res. 1987; 144: 2654-9.
34. Huff KK, Knabbe C, Lindsey R, Kaufman D, Bronzert D, Lippman ME, Dickson RB. Multihormonal regulation of insulin-like growth factor-1 -related protein in MCF-7 human breast cancer cells. Mol Endcrinol 1988; 2: 200-8.
35. Dickson RB, Huff KK, Spencer EM, Lippman ME. Introduction of epidermal growth factor related polipeptides by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinol 1986; 118: 138-42.
36. Page MJ, Field JK, Everett P, Green CD. Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 1983; 43: 1244-50.
37. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. Proliferation, hormonal responsiveness and estrogen receptor content of MCF-7 human breast cancer cells growth in the short-term and long-term absence of estrogens. Cancer Res 1987; 47: 4355-60.
38. Aakvaag A, Utaacker E, Thorsen T, Lea OA, Lahooti H. Growth control of human mammary cancer cells (MCF-7 cells) in culture: Effect of estradiol and growth factors in serum containing medium. Cancer Res 1990; 50: 7806-10.
39. Deil'aquilla ML, Pigott DA, Bonaquist DL, Gaffney EV. A factor from plasma derived human serum that inhibits the growth of the mammary cell line MCF-7: characterization and purification. J Natl Cancer Inst 1984; 72: 291-8.
40. Markaverich BM, Gregory RR, Alejandro MA, Clark JH, Johnson GA, Middleditch BS. Methyl p-hydroxphenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-11 binding sites. J Biol Chem 1988; 263: 7203-10.
41. Wellings SR. Development of human breast cancer. Adv Cancer Res 1980; 31: 287-99.
42. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of 16 human breasts with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55: 231-75.
43. Muggins C, Grand LC, Brillantes FP. Critical significance of breast structure in the induction of mammary cancer in the rat. Proc Natl Acad Sci USA 1959; 45: 1294-300.
44. Huggins C, Yang NC. Induction and extinction of mammary cancer. Science 1962; 137: 25-8.
45. Rogers AE, Lee SY. Chemically-induced mammary gland tumors in rats: modulation by dietary fat. In: Ip C, Birt DF, Rogers AE, Mettlin C (eds) Dietary Fat and Cancer, New York: Alan R LISS, 1986; 255-68.
46. Russo J, Russo IH. Biological and molecular bases of mammary carcinogenesis. Lab Invest 1987; 57: 112-37.
47. Russo J, Russo IH, Ireland M, Saby J. Increased resistance of multiparous rat mammary gland to neoplastic transformation by 7, 12-DMBA. Proc Am Assoc Cancer Res 1977; 18:140.
48. Russo J, Russo IH (1978) DNA-labeling index and structure of the rat mammary gland as determinant of its susceptibility to carcinogenesis. J Natl Cancer Inst 1978; 61: 1451-9.
49. Russo J, Russo IH. Susceptibility of the mammary gland to carcinogenesis II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol 1980; 100: 497-511.
50. Russo J, Russo IH. influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis Cancer Res. 1980; 40: 2677-87.
51. Chan PC, Dao TL. Effects of dietary fat on age-dependent sensitivity to mammary carcinogenesis. Cancer Letters 1983; 18: 245-53.
52. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 1985; 45: 3415-43.
53. Thompson HJ, Ronan A. Effect of L-a-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by l-methyl-l-nitrosourea. Carcinogenesis 1987; 57: 2003-9.
54. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol, Biomarkers & Prevention 1994; 3: 353-64.
55. Russo J, Russo IH. Hormonally induced differentiation: A novel approach to breast cancer prevention. J Cell Biochem 1995; 22: 58-64.
56. Russo IH, Gimotty P, Dupuis M, Russo J. Effect of Medroxyprogesterone Acetate on the Response of the Rat Mammary Gland to Carcinogenesis. British J of Cancer 1989; 59: 210-6.
57. Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Brit J Cancer 1991; 64: 481-4.
58. Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 1978; 61: 1439-42.
59. Russo IH, Russo J. Hormone prevention of mammary carcinogenesis: A new approach in anticancer research. Anticancer Res 1988; 8: 1247-64.
60. Russo IH, Russo J. Hormone prevention of mammary carcinogenesis by norethynodrelmestranol. Breast Cancer Res Treat 1989; 14: 43-56.
61. Russo IH, Russo J. Physiological basis of breast cancer prevention. European J Cancer Prevention 1993; 2: 101-11.
62. Russo IH, Russo J. Role of hCG and inhibin in breast cancer (Review), Int J Oncol 1994; 4: 297-306.
63. Ciocca DR, Parente A, Russo J. Endocrinological milieu and susceptibility of the rat mammary gland to carcinogenesis. Am J Pathol 1982; 109: 47-56.
64. Tay LK, Russo J. 7,12-Dimethylbenz(a)anthracene (DMBA) induced DNA binding and repair synthesis in susceptible and non-susceptible mammary epithelial cells in culture. J Natl Cancer Inst 1981; 67: 155-61.
65. Tay LK, Russo J. Formation and removal of 7,12-dimethylbenz(a)anthracene nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Carcinogenesis 1982; 2: 1327-33.
66. Tay LK, Russo J. Effect of human chorionic gonadotropin on 7, 12-dimethylbenz (a)anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Chem-Biol Interact 1985; 55: 13-21.
67. Berenblum I. A speculative review: the probable nature of promoting action, its significance in the understanding of the mechanism of carcinogenesis. Cancer Res 1976; 14: 471-6.
68. Frei JV, Harsano T. Increased susceptibility to low doses of carcinogen of epidermal cells in stimulated DNA synthesis. Cancer Res 1967; 27: 1482-91.